Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.10NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBL.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBL.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.24.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.24.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GY.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.7NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FY.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HH.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.5.85NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.85NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FU.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FU.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FY.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.3.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HH.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.7NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.22.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.22.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GY.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.6NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HW.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HW.1.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FY.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.5.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.38NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GY.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.2.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBC.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.6NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FY.4.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.4.1.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.13NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.16.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.5.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.62NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GW.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-24085.8US
XBB.2.3.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used